HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED) .
Status Recruiting
*.- Last follow-up date : 2018-12 (Anticipated)
*.- Primary completion date : 2018-03 (Anticipated).
*.- Sponsor : Sylentis, S.A.